| Trial ID: | L1112 |
| Source ID: | NCT00912782
|
| Associated Drug: |
Vitamin D3
|
| Title: |
Vitamin D and Arteriovenous Fistulae
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00912782/results
|
| Conditions: |
End-stage Renal Disease
|
| Interventions: |
DRUG: Vitamin D3|DRUG: Placebo
|
| Outcome Measures: |
Primary: Arteriovenous Fistulae Maturation, Maturation of an AVF is the ability to stick the AVF with two large bore needles at ≥ 6 consecutive dialysis sessions, and achievement of an AVF blood flow \>300 ml/min, assessed at six months following AVF creation., 6 months | Secondary: 25-hydroxyvitamin D and Serum Calcium, 10 weeks
|
| Sponsor/Collaborators: |
Sponsor: Emory University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
52
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-01
|
| Completion Date: |
2011-06
|
| Results First Posted: |
2014-07-02
|
| Last Update Posted: |
2014-07-02
|
| Locations: |
Emory University, Atlanta, Georgia, 30322, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00912782
|
